Company Overview
About Kilobaser
Kilobaser is a Vienna, Austria-based biotechnology hardware company — backed by Y Combinator (W21) with $1.99 million in total funding from BioTools Innovator — providing research laboratories and life sciences companies with desktop DNA and RNA oligonucleotide synthesizers that enable individual scientists to produce custom synthetic DNA sequences directly on their benchtops without sending samples to commercial synthesis services, generating $3.1 million in annual revenue in 2024 with consistent revenue growth since the 2014 company founding. Positioned as the "Nespresso Machine for DNA," Kilobaser offers the Basic Edition synthesizer ($35,500) and Extended Edition ($49,500) — compact, affordable instruments that democratize access to on-demand DNA synthesis for research labs that need rapid turnaround on custom oligonucleotide sequences for PCR primers, CRISPR guides, sequencing adapters, and synthetic gene construction.
Business Model & Competitive Advantage
Kilobaser's desktop DNA synthesis model addresses the supply chain bottleneck created by commercial oligonucleotide synthesis services: research labs currently order custom DNA sequences from commercial providers (Integrated DNA Technologies, Twist Bioscience, Genewiz) and wait 24-72 hours for overnight shipping of the synthesized oligos — a turnaround time that creates calendar friction in experiments requiring iterative sequence optimization (CRISPR guide RNA screening, primer optimization, aptamer selection) where the researcher wants results in the same day. Kilobaser's benchtop synthesizer (automated solid-phase phosphoramidite chemistry in a compact instrument format) enables on-demand synthesis of custom 8-30mer DNA sequences within 3-4 hours in the researcher's own lab — supporting the rapid design-synthesize-test cycles that accelerate research. The cartridge-based reagent system (comparable to Nespresso's pod approach) simplifies the chemistry consumable management that makes traditional DNA synthesis instruments impractical for non-specialist labs.
Competitive Landscape 2025–2026
In 2025, Kilobaser competes in the benchtop DNA synthesis instruments, oligonucleotide manufacturing, and life sciences research equipment market with Twist Bioscience (NASDAQ: TWST, synthetic DNA and oligo pools), Integrated DNA Technologies (Danaher subsidiary, NYSE: DHR, large-scale commercial oligo synthesis), and Evonetix (benchtop DNA synthesis instrument, $30M raised) for research lab on-demand DNA synthesis adoption. The democratization of DNA synthesis (making gene construction tools available to individual researchers rather than only centralized synthesis facilities) is a recurring theme in life sciences tool innovation — Kilobaser's benchtop instrument follows the pattern of PCR (made accessible by low-cost thermal cyclers), DNA sequencing (made accessible by benchtop sequencers like Oxford Nanopore's MinION), and cell counting. Y Combinator W21 backing positioned Kilobaser in the biotech tools investor community. The 2025 strategy focuses on growing the academic lab market (individual PI labs at universities), building the RNA synthesis capability extension (for siRNA and mRNA research), and expanding the reagent cartridge subscription revenue model.
Recent Activity
View all →Key Differentiators
Emerging Innovator
Kilobaser is an emerging player bringing innovative solutions to the Healthcare market.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
athenahealth
athenahealth is a cloud-based electronic health records (EHR), medical billing, and practice management company founded in 1997 and headquartered in Watertown, Massachusetts. The company was built on
Epic Systems
Epic Systems Corporation was founded in 1979 by Judith Faulkner and is headquartered in Verona, Wisconsin, remaining privately held with Faulkner as majority owner. The company develops large-scale el
Oracle Health
Oracle Health is the healthcare technology business unit of Oracle Corporation (NYSE: ORCL) — providing electronic health records (EHR), clinical workflow management, health information exchange, reve
Pfizer
Pfizer is one of the world's largest biopharmaceutical companies, founded in 1849 by cousins Charles Pfizer and Charles Erhart in Brooklyn, New York, and now headquartered in New York City. The compan
Moderna
Moderna is a clinical-stage biotechnology company that pioneered the development of messenger RNA (mRNA) therapeutics and vaccines, founded in 2010 by Noubar Afeyan, Robert Langer, Kenneth Chien, Stép
Amgen
Amgen Inc. is one of the world's largest biotechnology companies, headquartered in Thousand Oaks, California. Founded in 1980 as Applied Molecular Genetics, Amgen pioneered the development of biologic
Compare Kilobaser with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Kilobaser? Verify your company email to claim this profile and keep its description, products, and FAQs up to date.
Claim Kilobaser Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Kilobaser vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →